11,749
Views
45
CrossRef citations to date
0
Altmetric
Review Article

Phytotherapy in treatment of Parkinson’s disease: a review

, &
Pages 355-362 | Received 12 Mar 2019, Accepted 08 May 2019, Published online: 29 May 2019

References

  • Ablat N, Lv D, Ren R, Xiaokaiti Y, Ma X, Zhao X, Sun Y, Lei H, Xu J, Ma Y, et al. 2016. Neuroprotective effects of a standardized flavonoid extract from safflower against a rotenone-induced rat model of Parkinson’s disease. Molecules. 21:1107.
  • Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F. 2005. Ginkgo biloba affords dose‐dependent protection against 6‐hydroxydopamine‐induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem. 1:94–104.
  • Ahmad M, Yousuf S, Khan MB, Ahmad AS, Saleem S, Hoda MN, Islam F. 2006. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson’s disease. Hum Exp Toxicol. 7:361–368.
  • Ahmad S, Khan MB, Hoda MN, Bhatia K, Haque R, Fazili IS, Jamal A, Khan JS, Katare DP. 2012. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence. Neurochem Res. 3:516–526.
  • Alok S, Jain SK, Verma A, Kumar M, Sabharwal M. 2013. Pathophysiology of kidney, gallbladder and urinary stones treatment with herbal and allopathic medicine: a review. Asian Pac J Trop Dis. 6:496–504.
  • Antonini A, Barone P, Ceravolo R, Fabbrini G, Tinazzi M, Abbruzzese G. 2010. Role of pramipexole in the management of Parkinson’s disease. CNS Drugs. 10:829–841.
  • Aruna K, Rajeswari PDR, Sankar SR. 2016. The effects of Oxalis corniculata L. extract against MPTP induced oxidative stress in mouse model of Parkinson’s disease. J Pharm Sci Res. 8:1136.
  • Beppe GJ, Dongmo AB, Foyet HS, Tsabang N, Olteanu Z, Cioanca O, Hancianu M, Dimo T, Hritcu L. 2014. Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease. BMC Complement Altern Med. 14:142.
  • Chan WS, Durairajan SSK, Lu JH, Wang Y, Xie LX, Kum WF, Koo I, Yung KK, Li M. 2009. Neuroprotective effects of astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture. Neurochem Int. 6:414–422.
  • Chaturvedi R, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK. 2006. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. Neurobiol Dis. 2:421–434.
  • Choi HS, Park MS, Kim SH, Hwang BY, Lee CK, Lee MK. 2010. Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. Molecules. 4:2814–2824.
  • de Oliveria DM, Barreto G, De Andrade DVG, Saraceno E, Aon-Bertolino L, Capani F, Dos Santos El Bachá R, Giraldez LD. 2009. Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochem Res. 2:215–220.
  • Farbood Y, Sarkaki A, Dolatshahi M, Mansouri SMT, Khodadadi A. 2015. Ellagic acid protects the brain against 6-hydroxydopamine induced neuroinflammation in a rat model of Parkinson’s disease. Basic Clin Neurosci. 2:83.
  • Gaki GS, Papavassiliou AG. 2014. Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson’s disease. Neuromolecular Med. 2:217–230.
  • Gao QG, Chen WF, Xie JX, Wong MS. 2009. Ginsenoside Rg1 protects against 6‐OHDA‐induced neurotoxicity in neuroblastoma SK‐N‐SH cells via IGF‐I receptor and estrogen receptor pathways. J Neurochem. 5:1338–1347.
  • Haleagrahara N, Siew CJ, Ponnusamy K. 2013. Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. J Toxicol Sci. 1:25–33.
  • Hasanpour-Dehkordi A, Solati K. 2016. The efficacy of three learning methods collaborative, context-based learning and traditional, on learning, attitude and behaviour of undergraduate nursing students: integrating theory and practice. J Clin Diagn Res. 4:VC01.
  • Hasanpour-Dehkordi A, Jivad N, Solati K. 2016. Effects of yoga on physiological indices, anxiety and social functioning in multiple sclerosis patients: a randomized trial. J Clin Diagn Res. 6:VC01.
  • Hong Z, Wang G, Gu J, Pan J, Bai L, Zhang S, Chen SD. 2007. Tripchlorolide protects against MPTP‐induced neurotoxicity in C57BL/6 mice. Eur J Neurosci. 6:1500–1508.
  • Hritcu L, Foyet HS, Stefan M, Mihasan M, Asongalem AE, Kamtchouing P. 2011. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. J Ethnopharmacol. 137:585–591.
  • Hwang O. 2013. Role of oxidative stress in Parkinson’s disease. Exp Neurobiol. 1:11–17.
  • Khatri DK, Juvekar AR. 2015. Propensity of Hyoscyamus niger seeds methanolic extract to allay stereotaxically rotenone-induced Parkinson’s disease symptoms in rats. Orient Pharm Expe Med. 4:327–339.
  • Khuwaja G, Khan MM, Ishrat T, Ahmad A, Raza SS, Ashafaq M, Javed H, Khan MB, Khan A, Vaibhav K, et al. 2011. Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies. Brain Res. 1368:254–263.
  • Kiasalari Z, Baluchnejadmojarad T, Roghani M. 2016. Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-Hydroxydopamine rat model of Parkinson's disease. Cell Mol Neurobiol. 36:521–530.
  • Kim HG, Park G, Piao Y, Kang MS, Pak YK, Hong SP, Oh MS. 2014. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson’s disease. Food Chem Toxicol. 65:293–300.
  • Kosaraju J, Chinni S, Roy PD, Kannan E, Antony AS, Kumar MS. 2014. Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism. Indian J Pharmacol. 2:176.
  • Kwon IH, Choi HS, Shin KS, Lee BK, Lee CK, Hwang BY, Lim SC, Lee MK. 2010. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson’s disease. Neurosci Lett. 1:29–33.
  • Lees AJ. 2012. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease: accuracy of clinical diagnosis of idiopathic Parkinson’s disease. Vol. 2. London: BMJ Publishing Group Ltd.; p. 34–39.
  • Lieu CA, Kunselman AR, Manyam BV, Venkiteswaran K, Subramanian T. 2010. A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism Relat Disord. 7:458–465.
  • Mansouri MT, Farbood Y, Sameri MJ, Sarkaki A, Naghizadeh B, Rafeirad M. 2013. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 2:1028–1033.
  • Martins WB, Rodrigues SA, Silva HK, Dantas CG, Junior W, Cardoso JC, Filho LX, Gomes MZ. 2016. Neuroprotective effect of Portulaca oleracea extracts against 6-hydroxydopamine-induced lesion of dopaminergic neurons. Acad Bras Cienc. 3:150–439.
  • Morroni F, Tarozzi A, Sita G, Bolondi C, Zolezzi Moraga JM, Cantelli-Forti G, Hrelia P. 2013. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson’s disease. Neurotoxicol. 36:63–71.
  • Mu X, He G, Cheng Y, Li X, Xu B, Du G. 2009. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol Biochem Behav. 4:642–648.
  • Niranjan R. 2014. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson’s disease: focus on astrocytes. Mol Neurobiol. 1:28–38.
  • Noelker C, Bacher M, Gocke P, Wei X, Klockgether T, Du Y, Dodel R. 2005. The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity. Neurosci Lett. 1:39–43.
  • Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, et al. 2015. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 12:1591–1601.
  • Rabiei Z, Bigdeli MR, Rasoulian B, Ghassempour A, Mirzajani F. 2012. The neuroprotection effect of pretreatment with olive leaf extract on brain lipidomics in rat stroke model. Phytomedicine. 10:940–946.
  • Rabiei Z, Jahanbazi S, Alibabaei Z, Rafieian-kopaei M. 2018. Antidepressant effects of oleuropein in male mice by forced swim test and tail suspension test. Middle East J Fam Med. 10:132.
  • Rabiei Z, Lorigooini Z, Kopaei MR. 2016. Effects of hydroalcoholic extract of Borago officinalis on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Bangladesh J Pharmacol. 4:824–829.
  • Rabiei Z, Mokhtari S, Asgharzade S, Gholami M, Rahnama S, Rafieian-kopaei M. 2015. Inhibitory effect of Thymus vulgaris extract on memory impairment induced by scopolamine in rat. Asian Pac J Trop Biomed. 10:845–851.
  • Rabiei Z, Naderi S, Rafieian-Kopaei M. 2017. Study of antidepressant effects of grape seed oil in male mice using tail suspension and forced swim tests. Bangladesh J Pharmacol. 4:397–402.
  • Rabiei Z, Rafieian-Kopaei M. 2014. Neuroprotective effect of pretreatment with Lavandula officinalis ethanolic extract on blood-brain barrier permeability in a rat stroke model. Asian Pac J Trop Med. 7:S421–S6.
  • Rabiei Z, Setorki M. 2018. Effect of hydroalcoholic Echium amoenum extract on scopolamine-induced learning and memory impairment in rats. Pharm Biol. 56:672–677.
  • Ren R, Shi C, Cao J, Sun Y, Zhao X, Guo Y, Wang C, Lei H, Jiang H, Ablat N, et al. 2016. Neuroprotective effects of a standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson’s disease. Sci Rep. 6:221–235.
  • Rezaei M, Alirezaei M. 2014. Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence. J Physiol Sci. 3:171–176.
  • Sedaghat R, Roghani M, Khalili M. 2014. Neuroprotective effect of thymoquinone, the Nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-Parkinsonian rat model. Iran J Pharm Res. 1:227.
  • Shobana C, Kumar RR, Sumathi T. 2012. Alcoholic extract of Bacopa monniera Linn. protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: a pilot study. Cell Mol Neurobiol. 7:1099–1112.
  • Solati K, Lo’Bat Ja’Farzadeh AH. 2016. The effect of stress management based on group cognitive-behavioural therapy on marital satisfaction in infertile women. J Clin Diagn Res. 7:VC01.
  • Solati K. 2016. Effectiveness of cognitive-behavior group therapy, psycho-education family, and drug therapy in reducing and preventing recurrence of symptoms in patients with major depressive disorder. J Chem Pharm Res. 4:3414–3418.
  • Solati K. 2017. The efficacy of mindfulness-based cognitive therapy on resilience among the wives of patients with schizophrenia. J Clin Diagn Res. 4:VC01.
  • Tysnes OB, Storstein A. 2017. Epidemiology of Parkinson’s disease. J Neural Transm. 8:901–905.
  • Van Kampen JM, Baranowski DB, Shaw CA, Kay DG. 2014. Panax ginseng is neuroprotective in a novel progressive model of Parkinson’s disease. Exp Gerontol. 50:95–105.
  • Wang Q, Liu Y, Zhou J. 2015. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener. 1:19.
  • Wang X, Liang XB, Li FQ, Zhou HF, Liu XY, Wang JJ, Wang XM. 2008. Therapeutic strategies for Parkinson’s disease: the ancient meets the future—traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochem Res. 10:1956–1963.
  • Williamson EM. 2001. Synergy and other interactions in phytomedicines. Phytomedicine. 5:401–409.
  • Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC, Tsai CW. 2015. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease: involvement of antioxidative enzymes induction. Che-Biol Interact. 225:40–46.
  • Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA. 2002. Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med. 6:600–606.
  • Zhang ZJ, Cheang LC, Wang MW, Li GH, Chu IK, Lin ZX. 2012. Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cell Mol Neurobiol. 1:27–40.
  • Zhao G, Jiang Z-H, Zheng X-w, Zang S-Y, Guo L-H. 2008. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract. Pharmacol Biochem Behav. 90:363–371.